PRECIGEN Investors


61st ASH Annual Meeting & Exposition

Dec 08, 2019 at 6:00 PM EST

Tim Chan, PhD, Senior Director, Immuno-Oncology of Precigen will present the poster “Preclinical Characterization of PRGN-3006 UltraCAR-T™ for the Treatment of AML and MDS: Non-Viral, Multigenic Autologous CAR-T Cells Administered One Day after Gene Transfer.” (Abstract #2660)


Orlando, FL